Notice of Preapplication Webinar for RFA-CA-22-016, Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional)
Notice Number:

Key Dates

Release Date:

June 7, 2022

Related Announcements

RFA-CA-22-016 - Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional)

Issued by

National Cancer Institute (NCI)


The NCI will hold a pre-application webinar on Thursday, July 14, 2022, from 3:00-4:00 PM (EDT) for the Funding Opportunity Announcement (FOA) RFA-CA-22-016 entitled "Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional)."

NCI staff members involved in these FOAs will provide orientation and programmatic guidance to potential applicants by explaining the goals and objectives of the Pediatric Immunotherapy Network and answering questions from attendees. Potential applicants are encouraged to submit their questions by July 12 to Slides will be available on the Division of Cancer Biology web page and Division of Cancer Treatment and Diagnosis webpage two days following the completion of the webinar. Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-22-016.

To join the webinar, pre-registration is required through WebEx (Webinar joining link will be provided upon registration).

Webinar Date: July 14, 2022
Time: 3:00-4:00 pm EDT


Please direct all inquiries to:

Anju Singh, B.V.Sc, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7603

Nita Seibel, M.D.
National Cancer Institute (NCI)
Telephone: 240-276-6560

Lillian Kuo, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7687